Evolving Treatment Strategies for Triple Negative Breast Cancer
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Make evidence-based neoadjuvant treatment recommendations for patients with triple negative breast cancer
Melinda Telli, MD
Stanford Cancer Institute
- 0.75 Participation
- 0.74 Nurse
- 0.75 Pharmacist
- 0.75 Physician